MEDICAL WRITING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025 - 2032)

Global Medical Writing Market Size and Forecast – 2025 to 2032

The Global Medical Writing Market is estimated to be valued at USD 5.10 Bn in 2025 and is expected to reach USD 10.26 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 10.5% from 2025 to 2032. This significant growth can be attributed to the increasing demand for regulatory documentation, clinical trial reports, and scientific publications in the pharmaceutical and healthcare industries, driven in part by the widespread adoption of clinical trial management systems such as Medidata Solutions and Oracle Health Sciences.

Key Takeaways of the global medical writing market:

• By type, clinical writing is expected to hold the largest market share at 35.6% in 2025.
• By application, oncology is expected to lead the medical writing market with a 24.3% share in 2025.
• By service provider, in-house medical writers segment is projected to dominate the market with a 54.3% share in 2025.
• North America is expected to lead the market, holding a share of 38.3% in 2025. Asia Pacific is anticipated to be the fastest-growing region, with a market share of 29.2% in 2025.

Market Overview:

The medical writing market is witnessing a growing trend of outsourcing, as pharmaceutical and biotechnology companies seek to reduce costs and improve efficiency. Additionally, the increasing complexity of regulatory requirements and the need for specialized expertise are driving the demand for professional medical writing services. The market is also benefiting from the adoption of advanced technologies, such as artificial intelligence and machine learning, which are helping streamline the medical writing process and improve the quality of outputs.

Currents Events and their Impact

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Segmental Analysis

To learn more about this report, Request sample copy

Medical Writing Market Insights, By Type - Clinical Writing Leads Due to Demand for Regulatory Documentation

In terms of type, clinical writing is expected to contribute the highest share of the market with 35.6% in 2025 owing to the increasing demand for clinical trial documentation and regulatory submissions. The growing number of clinical trials across various therapeutic areas, coupled with the stringent regulatory requirements for drug development, has fueled the need for expert clinical writing services.

Clinical writing involves the creation of a wide range of documents, including clinical study protocols, investigator brochures, clinical study reports, and patient informed consent forms. These documents play a crucial role in ensuring the integrity, transparency, and reproducibility of clinical trials, which are essential for the successful development and approval of new drugs and medical devices.

Medical Writing Market Insights, By Application - Oncology Leads the Market by Application, Driven by Cancer Prevalence and Advancements in Treatment

In terms of application, oncology is expected to contribute the highest share of the medical writing market with 24.3% in 2025 driven by the increasing prevalence of cancer worldwide and the rapid advancements in cancer research and treatment. For instance, according to data published by the WHO in February 2025, cancer remains a leading cause of death worldwide, causing nearly 10 million deaths in 2020—about one in six globally. The most common cancers diagnosed that year were breast, lung, colorectal, prostate, non-melanoma skin, and stomach cancers. The development of novel cancer therapies, such as targeted drugs, immunotherapies, and combination treatments, has created a significant demand for medical writing services in this field.

Oncology clinical trials are among the most complex and challenging, often involving multiple treatment arms, biomarker-driven patient selection, and long-term follow-up. Medical writers specializing in oncology play a vital role in creating clear, concise, and scientifically accurate documents that effectively communicate the results of these trials to regulatory authorities, healthcare professionals, and patients.

Medical Writing Market Insights, By Service Provider - In-house Medical Writers Hold the Largest Share Due to Greater Control and Expertise

In terms of service provider, in-house medical writers contribute the highest share of the medical writing market, with an estimated share of 54.3% in 2025 as many pharmaceutical and biotechnology companies prefer to maintain their own teams of experienced medical writers. In-house medical writers offer several advantages, including a deep understanding of the company's products, therapeutic areas, and strategic goals, as well as the ability to ensure consistency and quality across all medical writing deliverables.

Having an in-house medical writing team allows companies to maintain greater control over the content and timelines of their medical writing projects. This is particularly important for sensitive or confidential projects, such as those related to new drug development or intellectual property.

Regional Insights

To learn more about this report, Request sample copy

North America Medical Writing Market Analysis and Trends

North America’s dominance in the global medical writing market with an estimated share of 38.3% in 2025 can be attributed to several factors. The region boasts a robust healthcare infrastructure, coupled with a high demand for quality medical content. The presence of major pharmaceutical and biotechnology companies, such as Pfizer, Johnson & Johnson, and Merck, drives the need for expert medical writing services. Moreover, stringent regulatory requirements set by the U.S. Food and Drug Administration (FDA) and other regulatory bodies necessitate meticulous documentation and clinical trial reports, further fueling the demand for medical writing professionals.

The region's advanced technological landscape and focus on research and development also contribute to its leading position in the market. For instance, Emmes Group, a global clinical research organization, partnered with Miimansa AI to use generative AI for faster clinical data processing. Integrating Miimansa’s AI tools into Emmes’ platform will speed up protocol writing and medical documentation, cutting time and costs.

Asia Pacific Medical Writing Market Analysis and Trends

The Asia Pacific region is expected to exhibit the fastest growth in the global medical writing market with a share of 29.2% in 2025. This growth can be ascribed to the rapidly expanding healthcare sector, increasing clinical trials, and rising investments in research and development. Countries like China, India, and Japan are witnessing a surge in pharmaceutical and biotechnology companies, leading to a heightened demand for medical writing services.

The region's large patient population and cost-effective clinical trial operations make it an attractive destination for global pharmaceutical companies. Additionally, government initiatives to promote healthcare innovation and streamline regulatory processes are further driving the growth of the medical writing market in the Asia Pacific region.

Global Medical Writing Market Outlook for Key Countries:

U.S. Medical Writing Market Trends

The U.S. medical writing market holds a significant share in the global medical writing market. The country's robust healthcare system, coupled with the presence of major pharmaceutical giants and a thriving biotechnology industry, creates a strong demand for medical writing services. Companies such as Covance, PAREXEL, and IQVIA play a pivotal role in providing comprehensive medical writing solutions. The U.S. medical writing market is characterized by strict regulatory requirements, emphasizing the need for high-quality clinical documentation and regulatory submissions.

 The country's focus on innovation and research further propels the growth of the medical writing market. For instance, in September 2023, Tessaera Therapeutics, a pioneer in gene writing technologies in the U.S., unveiled significant progress in its platforms, showcasing gene writers’ ability to deliver therapeutic messages in the genome of non-human primates.

China Medical Writing Market Trends

China's market is experiencing rapid growth in the global medical writing market. The country's expanding healthcare sector, coupled with increasing investments in research and development, is driving the demand for medical writing services. Chinese pharmaceutical companies, such as Sinopharm and Sinovac, are making significant strides in drug development and clinical trials. The government's initiatives to streamline regulatory processes and encourage innovation in the healthcare industry are further boosting the market's growth.

For instance, in March 2023, AlphaLife Sciences, a clinical research technology provider, partnered with CSPC Pharmaceutical Group, a leading Chinese pharma company, to launch AuroraPrime Create in March 2023. This intelligent system streamlines the generation of clinical research documents like protocols and study reports, enhancing content quality, team collaboration, and approval efficiency.

Japan Medical Writing Market Trends

Japan medical writing market holds a notable position in the global medical writing market. The country's advanced healthcare system and a strong emphasis on research and development contribute to the demand for medical writing services. Japanese pharmaceutical companies, such as Takeda and Astellas, are actively engaged in drug development and clinical trials. The country's aging population and increasing prevalence of chronic diseases further drive the need for medical writing expertise.

For example, CMIC Group, a leading contract research organization (CRO) in Japan, offers comprehensive medical writing services throughout all stages of product development. Their experienced team prepares clinical study documents such as protocols, informed consent forms, investigator brochures, clinical study reports, and regulatory dossiers including New Drug Applications (NDA) and Periodic Safety Reports..

U.K. Medical Writing Market Trends

The U.K. medical writing market is evolving with growing demand for precise regulatory and clinical documents driven by changing Medicines and Healthcare products Regulatory Agency (MHRA) and European Medicines Agency (EMA) guidelines. Specialized expertise in areas like oncology and personalized medicine is increasingly valued. Adoption of Artificial Intelligence (AI) and digital tools is improving efficiency and accuracy.

For instance, in March 2023, Nuance Communications, a Microsoft company known for its AI-driven speech recognition tools, launched DAX Express, an AI-powered, GPT-4-enabled app that reduces doctors’ administrative burden by integrating conversational and ambient AI into the clinical workflow.

End User Feedback and Unmet Needs

• End users across key sectors such as pharmaceutical companies, contract research organizations (CROs), regulatory agencies, and academic institutions consistently value accuracy, regulatory compliance, and timely delivery in medical writing services. Positive feedback often highlights AI-driven platforms that integrate smoothly with existing data systems, enabling faster and more consistent report generation. For example, a leading CRO reported that using an AI-enabled tool reduced clinical study report turnaround time by 30%, improved documentation quality, and allowed writers to focus on complex analysis rather than routine tasks. However, many smaller biotech firms and government bodies express concerns about limited customization options, high costs, and poor integration with legacy systems. These users find it challenging to tailor documents to regional regulatory standards and face barriers due to steep learning curves and insufficient customer support.

• The market’s unmet needs primarily involve technological adaptability, enhanced customization, affordability, and better support. Developing modular, user-friendly platforms that offer flexible configurations and integrate with diverse data sources could significantly improve customer satisfaction and retention. Introducing cost-effective pricing models would enable smaller organizations to access advanced medical writing tools, expanding market reach. Policymakers encouraging standardization and interoperability can further promote innovation. Addressing these gaps presents substantial growth opportunities by improving operational efficiency, broadening adoption across varied end users, and fostering long-term loyalty, thereby driving sustained innovation and expansion in the global medical writing market.

Market Players, Key Developments, and Competitive Intelligence:

To learn more about this report, Request sample copy

Key Developments:

• In January 2025, AINGENS, a U.S.-based AI solutions provider for the life sciences sector, launched MACg (Medical Affairs Content Generator), a multimodal AI-powered platform for medical writing, research, and reference management. Powered by OpenAI GPT-4.0, MACg offers PubMed search, editing, citation support, and reference tools, streamlining scientific content creation for biotech, pharma, research, and academic professionals.
• In February 2025, Indegene introduced Cortex, an AI-powered platform designed specifically for the Life Sciences industry. Cortex aims to streamline workflows, improve efficiency, and enhance decision-making across various functions such as medical affairs, regulatory, and commercial operations in pharmaceutical and biotech companies.
• In November 2024, Biolevate, a health-tech startup startup, raised USD 6.8 million in Seed funding led by EQT Ventures to accelerate the slow, labor-intensive medical writing process in the drug development sector.
• In July 2024, Certara, a global leader in regulatory science and drug development solutions, uses AI to tackle pharma medical writing challenges. Although transformer-based language models can generate human-like text, they may produce inaccurate information and lack domain-specific knowledge required for compliance with the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA).

Top Strategies Followed by Global Medical Writing Market Players

• Established players in the global medical writing market are focusing on extensive research and development to innovate high-performance products. These companies are investing heavily in R&D to develop advanced medical writing solutions that cater to the evolving needs of the healthcare industry. Additionally, strategic partnerships with major industry players and original equipment manufacturers (OEMs) are crucial for solidifying market presence. These alliances enable established players to leverage the expertise and resources of their partners, thereby strengthening their position in the market.
  • For instance, in June 2024, TrialAssure, a company in pharmaceutical technology, introduced TrialAssure LINK AI 2.0 at the June 2024 DIA Conference in San Diego. This AI tool helps drug and biotech companies, and research groups, by automatically creating important medical documents like study protocols, reports, safety summaries, and consent forms. It makes writing these papers faster and easier.

• Mid-level players in the global medical writing market are concentrating on delivering cost-effective solutions to target price-sensitive consumers. These companies are focusing on providing quality products at affordable prices to gain a competitive edge in the market. Moreover, collaborations with other industry players are essential for mid-level companies to boost their technology, production capabilities, and market presence. By partnering with companies that have complementary expertise and resources, mid-level players can enhance their offerings and expand their reach in the market.
  • For instance, in July 2024, Insilico Medicine, a company in AI-driven drug discovery, launched DORA, a new AI assistant designed to help draft medical research papers. Unlike typical instant-response AI, DORA supports writing academic papers, case studies, and applications for grants and patents. Aimed especially at early-career researchers and non-native English speakers, a free trial will be available later this year to assist in expanding medical research contributions.

• Small-scale players in the global medical writing market are targeting niche markets with unique features and innovative products. These companies are leveraging their expertise in specific areas to develop specialized solutions that cater to the unique needs of their target customers. Additionally, small-scale players are adopting cutting-edge technologies to remain competitive in the market.
  • For example, Enago Life Sciences specializes in medical writing and editing for academic and clinical research, using AI tools and partnering with regional publishers and universities. Meditech Media is a boutique firm offering tailored regulatory and scientific writing, focusing on rare diseases and niche areas, collaborating with startups and local pharma to expand reach.

Market Report Scope

Medical Writing Market Dynamics

To learn more about this report, Request sample copy

Medical Writing Market Driver - Increasing Demand for Clinical Trial Documentation

The growing demand for clinical trial documentation is a significant driver propelling the growth of the global medical writing market. As pharmaceutical and biotechnology companies continue to invest heavily in research and development, the need for comprehensive and well-structured clinical trial documentation becomes increasingly crucial. Medical writers play a vital role in ensuring that clinical trial protocols, reports, and regulatory submissions are prepared accurately and in compliance with stringent guidelines set by regulatory authorities. The increasing complexity of clinical trials, coupled with the rising number of pipeline drugs and therapies, further fuels the demand for skilled medical writers who can effectively communicate scientific findings and data.

Moreover, the globalization of clinical trials has led to a greater requirement for standardized documentation across different regions and regulatory frameworks, further emphasizing the importance of medical writing services in the industry. For instane, in January 2025, ICON plc, a global clinical research leader, expanded its AI tools to improve clinical trial efficiency across study startup, document management, resource forecasting, and reporting. Supported by an Enterprise Ireland grant, its AI Centre of Excellence ensures ethical, effective AI solutions.

Medical Writing Market Opportunity - Expansion of Pharmaceutical and Biotechnology Sectors

The expansion of the pharmaceutical and biotechnology sectors presents a significant opportunity for the global medical writing market. As these industries continue to grow and innovate, the demand for medical writing services is expected to rise substantially. Pharmaceutical and biotechnology companies require a wide range of medical writing support, including clinical trial protocols, regulatory submissions, scientific publications, and marketing materials. The increasing complexity of drug development processes, coupled with stringent regulatory requirements, has made medical writing an essential component of the product lifecycle. Moreover, the globalization of these sectors has created new opportunities for medical writing services, as companies seek to navigate diverse regulatory landscapes and communicate effectively with international audiences. The growth of the pharmaceutical and biotechnology sectors is likely to drive the demand for specialized medical writing expertise, creating lucrative opportunities for market players who can deliver high-quality, timely, and compliant medical writing solutions.

In September 2024, ICROM s.r.l., a leading company in the field of pharmaceutical research and development acquired HOLODIAG sas, a Contract Research Organization (CRO) specializing in pharma solid-state and crystallization processes for small molecules. This acquisition will leverage synergies and combine resources, significantly enhancing the growth, size, and capabilities of HOLODIAG sas.

Analyst Opinion (Expert Opinion)

• The global medical writing market is witnessing robust growth driven by technological advancements such as AI-assisted writing tools and cloud-based collaboration platforms that enhance efficiency and accuracy. Regulatory support from agencies worldwide demanding comprehensive and compliant documentation for clinical trials and drug approvals further fuels demand. Rising investments in pharmaceutical R&D, increasing complexity of clinical trials, and the growing prevalence of chronic diseases are additional key drivers. However, challenges such as stringent regulatory environments, high dependence on skilled medical writers, and data security concerns remain. Emerging opportunities lie in specialized medical writing for niche therapeutic areas and expansion in emerging markets with increasing clinical research activities.
• Notable industry events like the DIA Global Annual Meeting, American Medical Writers Association (AMWA) Conference, and the European Medical Writers Association (EMWA) Workshop have significantly contributed to advancing knowledge, networking, and best practice dissemination in the medical writing domain over the past few years. These forums have facilitated policy dialogue, technology showcases, and skill development essential to market evolution. Real-world initiatives such as Meditech Media’s partnerships with biotech startups for rare disease documentation and regulatory pilot programs by the U.S. FDA promoting electronic submissions underscore ongoing innovation and regulatory alignment that are expected to positively shape the market’s trajectory globally.

Market Segmentation

•  Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Clinical Writing
  • Regulatory Writing
  • Medical Education Writing
  • Medical Marketing Writing
  • Scientific Publications Writing
•  Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Oncology
  • Cardiovascular
  • Neurology
  • Infectious Diseases
  • Rare Diseases
  • Others
•  Service Provider Insights (Revenue, USD Bn, 2020 - 2032)
  • In-house Medical Writers
  • Outsourced Medical Writing Services
•  End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Medical Device Manufacturers
  • Healthcare Professionals
  • Academic & Research Organizations
  • Regulatory Authorities
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Parexel International Corporation
  • Covance Inc.
  • Medpace Holdings, Inc.
  • ICON plc
  • Charles River Laboratories
  • Syneos Health
  • PPD (Pharmaceutical Product Development)
  • PRA Health Sciences
  • WuXi AppTec
  • KCR S.A.
  • InVentiv Health
  • Celerion
  • BioClinica
  • Quorum Review IRB
  • FSP (Functional Service Provider)

Sources

Primary Research Interviews:

• Interviews with Clinical Research Organisations (CROs) Medical Writing Teams
• Discussions with Pharmaceutical and Biotechnology Regulatory Affairs Experts
• Consultations with Medical Writing Professionals in Academia and Hospitals
• Surveys with Regulatory Bodies’ Medical Writers and Reviewers
• Interviews with Clinical Trial Managers and Principal Investigators

Databases:

• U.S. Food and Drug Administration (FDA) — Drug Development and Approval Data
• European Medicines Agency (EMA) — Regulatory Documentation Guidelines and Reports
• National Institutes of Health (NIH) — Clinical Trials Data and Publications
• World Health Organization (WHO) — Global Health Regulations and Clinical Guidelines
• Centers for Disease Control and Prevention (CDC) — Research and Surveillance Data
• gov — Registry of Clinical Trials and Study Documentation
• European Clinical Trials Database (EudraCT) — Clinical Study Information

Magazines:

• The Write Stuff (Journal of the European Medical Writers Association)
• AMWA Journal (American Medical Writers Association)
• Medical Writing Journal (International Society for Medical Publication Professionals)
• Pharmaceutical Executive Magazine (Non-commercial editorial sections)
• Regulatory Focus (by Regulatory Affairs Professionals Society - RAPS)

Journals:

• Journal of Clinical Research & Bioethics
• Trials (Open Access Journal on Clinical Trials)
• PLoS ONE (Public Library of Science) – Articles on Clinical Trial Reporting
• Medical Writing (Official journal of AMWA)
• Research Integrity and Peer Review
• Journal of Medical Internet Research

Newspapers:

• Reuters Health
• BBC Health Section
• The Guardian – Science and Health
• The New York Times – Health and Science
• Science Daily
• Nature News

Associations:

• American Medical Writers Association (AMWA)
• European Medical Writers Association (EMWA)
• International Society for Medical Publication Professionals (ISMPP)
• Regulatory Affairs Professionals Society (RAPS)
• Drug Information Association (DIA)

Public Domain Sources:

• OpenTrials — Open Database of Clinical Trials Data
• Health Data from World Bank Open Data
• WHO Global Health Observatory Data Repository
• NIH RePORTER — Funding and Research Project Database
• Google Scholar (for academic literature searches)
• Clinical Study Protocols and Templates publicly available

Proprietary Elements:

• CMI Data Analytics Tool: Proprietary analytics tool to analyze real-time market trends, consumer behavior, and technology adoption in market
• Proprietary CMI Existing Repository of Information for Last 8 Years